推进土壤风险评估:使用补充性毒动力学-毒动力学建模方法进行新型地子测试
Kim Rakel1, Vanessa Roeben2, Gregor Ernst2
1Research Institute gaiac, Aachen, Germany.
Environmental toxicology and chemistry
|August 22, 2024
概括
一项新的土试验为农药风险评估中的毒动力学-毒动力学 (TKTD) 建模提供了数据. 这种方法改进了对碳酸的理解.
科学领域:
- 环境毒理学环境毒理学
- 生态毒理学 生态毒理学
- 土壤生物风险评估评估
背景情况:
- 目前的欧盟农药风险评估依赖于一级和现场研究.
- 毒动力学-毒动力学 (TKTD) 建模为解决风险评估中的不确定性提供了一个有希望的方法.
- 经合组织222标准的土测试没有为TKTD建模提供所需的时间序列数据.
研究的目的:
- 介绍一款用于生成时间解析数据的新型地试验设计.
- 为了使TKTD建模在土壤生物风险评估中的实施.
- 为了研究碳素对土的长期生长和繁殖的有毒影响.
主要方法:
- 一个经合组织222修改的土虫试验,每隔7天 (7,14,21,28) 进行破坏性采样.
- 确定虫的生长,子的生产,以及幼的化成功.
- 将数据应用于动态能源预算理论-TKTD模型的Eisenia fetida.
主要成果:
- 新的测试设计成功提供了关于虫生长和繁殖的时间序列数据.
- 暴露于高度的碳扎胺显著降低了生长和子生产.
- 确定了不同的作用模式:对生长的主要影响 (增加维护成本) 和对繁殖和化成功的次要影响.
结论:
- 开发的土试验适合用于农药风险评估中的TKTD建模.
- 试验设计提高了对化学物质对土壤生物的影响的理解.
- 这种方法可以通过提供更详细的毒理洞察来完善当前的风险评估策略.
更多相关视频
09:39Physical, Chemical and Biological Characterization of Six Biochars Produced for the Remediation of Contaminated Sites
Published on: November 28, 2014
35.1K
09:01A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans
Published on: March 14, 2019
7.2K
相关概念视频
Toxicokinetics: Overview
253
Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
253
Toxicity Testing in Animals
170
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
170
